ECONAZOLE NITRATE

ECONAZOLE NITRATE was reported 947 times

ECONAZOLE NITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCAN WITH CONTRAST ABNORMAL 2 0.1111
1 PURPURA SENILE 12 0.0984
2 BLOOD PYRUVIC ACID DECREASED 2 0.0952
3 ANGIODERMATITIS 7 0.0824
4 LACTATE PYRUVATE RATIO INCREASED 3 0.0652
5 CONGENITAL ECTOPIC BLADDER 3 0.0625
6 TARSAL TUNNEL SYNDROME 12 0.0545
7 ESCHERICHIA VAGINITIS 1 0.0455
8 MALASSEZIA INFECTION 2 0.0294
9 CHRONIC ACTINIC DERMATITIS 1 0.0286
10 MENINGORADICULITIS 3 0.0278
11 AMNIOTIC FLUID INDEX DECREASED 1 0.0278
12 CYSTOCELE REPAIR 1 0.0233
13 INTRACARDIAC PRESSURE INCREASED 2 0.0227
14 NEUTROPENIA NEONATAL 5 0.0223
15 BLOOD KETONE BODY DECREASED 1 0.0213
16 AMIMIA 2 0.0182
17 FAMILIAL TREMOR 1 0.0169
18 INTERCOSTAL NEURALGIA 3 0.0169
19 CARDIAC PACEMAKER BATTERY REPLACEMENT 1 0.0147
20 RESORPTION BONE INCREASED 12 0.0146
21 PRESBYACUSIS 4 0.0130
22 CHONDRODYSTROPHY 1 0.0127
23 FUNGAL TEST POSITIVE 4 0.0114
24 APPLICATION SITE FISSURE 1 0.0111
25 FOETAL MACROSOMIA 3 0.0108
26 THYMUS DISORDER 2 0.0105
27 DYSHIDROSIS 1 0.0104
28 FOETAL HEART RATE DISORDER 2 0.0104
29 BRAIN COMPRESSION 4 0.0100
30 VESTIBULAR DISORDER 12 0.0098
31 BRONCHOALVEOLAR LAVAGE ABNORMAL 2 0.0096
32 DYSTHYMIC DISORDER 3 0.0090
33 LARYNGOMALACIA 3 0.0090
34 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
35 FEMORAL ARTERIAL STENOSIS 1 0.0088
36 CARDIAC FAILURE HIGH OUTPUT 2 0.0083
37 INCISION SITE DISCHARGE 2 0.0079
38 DIARRHOEA NEONATAL 1 0.0079
39 FEVER NEONATAL 1 0.0076
40 FOETAL ARRHYTHMIA 2 0.0074
41 CATHETERISATION CARDIAC ABNORMAL 2 0.0074
42 PERIVENTRICULAR LEUKOMALACIA 2 0.0071
43 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
44 AMNIOTIC FLUID VOLUME INCREASED 1 0.0063
45 VERTIGO POSITIONAL 11 0.0063
46 CARDIAC OUTPUT INCREASED 1 0.0058
47 CARDIOACTIVE DRUG LEVEL DECREASED 1 0.0058
48 NAIL DYSTROPHY 3 0.0054
49 BLOOD KETONE BODY PRESENT 1 0.0053
50 CORNEAL REFLEX DECREASED 2 0.0053
51 OCCIPITAL NEURALGIA 3 0.0053
52 SCROTAL ABSCESS 2 0.0053
53 DYSLEXIA 6 0.0052
54 CONGENITAL MEGAURETER 1 0.0052
55 OESOPHAGEAL INJURY 2 0.0052
56 GENITAL ABSCESS 2 0.0050
57 CAROTID ENDARTERECTOMY 1 0.0048
58 JOB DISSATISFACTION 3 0.0046
59 ENDARTERECTOMY 1 0.0045
60 NEUROSIS 2 0.0044
61 ALLERGY TO PLANTS 2 0.0044
62 MACROCYTOSIS 5 0.0043
63 ENDOTHELIAL DYSFUNCTION 1 0.0043
64 CREST SYNDROME 1 0.0042
65 LOWER RESPIRATORY TRACT INFECTION VIRAL 2 0.0040
66 BLOOD KETONE BODY INCREASED 3 0.0038
67 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 1 0.0037
68 INTERTRIGO 2 0.0037
69 THROMBOPHLEBITIS SUPERFICIAL 11 0.0036
70 CHOLESTEATOMA 1 0.0036
71 PERIORBITAL PAIN 3 0.0035
72 BACTERIAL TEST 1 0.0034
73 MENINGOMYELOCELE 2 0.0033
74 BIOPSY BREAST 1 0.0032
75 FEMORAL ARTERY OCCLUSION 1 0.0032
76 NEONATAL DISORDER 5 0.0032
77 URINE LEUKOCYTE ESTERASE POSITIVE 2 0.0029
78 BREAST HYPERPLASIA 1 0.0028
79 DIALYSIS RELATED COMPLICATION 1 0.0028
80 BLOOD CHLORIDE DECREASED 7 0.0027
81 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
82 ALLODYNIA 3 0.0026
83 ARACHNOID CYST 1 0.0025
84 TINEA PEDIS 4 0.0025
85 PANCREATITIS RELAPSING 2 0.0024
86 BALANOPOSTHITIS 2 0.0024
87 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
88 CLEFT LIP 2 0.0023
89 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2 0.0022
90 DIABETIC EYE DISEASE 1 0.0022
91 RHONCHI 3 0.0022
92 DYSPHASIA 1 0.0021
93 ECZEMA ASTEATOTIC 1 0.0021
94 BLOOD BICARBONATE INCREASED 1 0.0021
95 ANAEMIA NEONATAL 1 0.0021
96 ARTERIOVENOUS FISTULA 1 0.0020
97 GENITAL ERYTHEMA 1 0.0020
98 PSYCHOTIC BEHAVIOUR 2 0.0020
99 APPLICATION SITE INFECTION 1 0.0020
100 AXILLARY MASS 2 0.0019
101 BONE DEMINERALISATION 2 0.0019
102 LIPODYSTROPHY ACQUIRED 4 0.0019
103 ACARODERMATITIS 2 0.0018
104 BODY TINEA 1 0.0018
105 APPLICATION SITE DISCHARGE 2 0.0017
106 FUNGAL SKIN INFECTION 7 0.0017
107 ENTERAL NUTRITION 1 0.0017
108 SKIN HYPOPIGMENTATION 3 0.0017
109 ADRENAL ADENOMA 1 0.0017
110 SELF ESTEEM DECREASED 4 0.0017
111 DERMAL CYST 4 0.0016
112 MALIGNANT MELANOMA IN SITU 2 0.0016
113 GASTRIC NEOPLASM 1 0.0016
114 MENOMETRORRHAGIA 3 0.0016
115 PHLEBITIS 8 0.0016
116 CELLULITIS STAPHYLOCOCCAL 1 0.0015
117 ANION GAP INCREASED 2 0.0015
118 FOETAL EXPOSURE DURING DELIVERY 1 0.0015
119 AKINESIA 3 0.0014
120 ATRIAL TACHYCARDIA 3 0.0014
121 FOETAL HYPOKINESIA 1 0.0014
122 DERMATITIS DIAPER 1 0.0014
123 GENITAL RASH 2 0.0014
124 CONGENITAL HYDRONEPHROSIS 1 0.0014
125 OCULOGYRIC CRISIS 3 0.0014
126 DENTAL RESTORATION FAILURE 1 0.0014
127 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
128 AORTIC VALVE SCLEROSIS 1 0.0014
129 BLUNTED AFFECT 1 0.0014
130 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
131 BLISTER RUPTURE 1 0.0013
132 DIAPHRAGMATIC DISORDER 1 0.0013
133 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
134 FOETAL GROWTH RETARDATION 1 0.0013
135 CROUP INFECTIOUS 1 0.0013
136 BLOOD FIBRINOGEN INCREASED 1 0.0013
137 AORTIC DISORDER 1 0.0013
138 BREAST CALCIFICATIONS 1 0.0013
139 CHEMICAL INJURY 1 0.0012
140 BREAST OPERATION 1 0.0012
141 CYTOLYTIC HEPATITIS 4 0.0012
142 GIANT CELL ARTERITIS 1 0.0012
143 VASCULITIS 14 0.0012
144 DEPERSONALISATION 1 0.0012
145 SPINAL DEFORMITY 2 0.0012
146 LEUKAEMIA RECURRENT 2 0.0012
147 FIXED ERUPTION 2 0.0012
148 BLOOD CHLORIDE INCREASED 2 0.0012
149 GINGIVAL ERYTHEMA 1 0.0012
150 GENITAL BURNING SENSATION 1 0.0012
151 SPONDYLOLISTHESIS 2 0.0012
152 BLOOD LACTIC ACID INCREASED 6 0.0011
153 BLOOD ALBUMIN INCREASED 1 0.0011
154 FIBROMA 1 0.0011
155 ARTHROPOD BITE 8 0.0011
156 JAUNDICE NEONATAL 2 0.0011
157 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
158 CLEFT PALATE 2 0.0010
159 EPIDERMAL NECROSIS 1 0.0010
160 NASAL SEPTUM DEVIATION 2 0.0010
161 MASTICATION DISORDER 3 0.0010
162 OSTEOLYSIS 2 0.0010
163 CHEST X-RAY ABNORMAL 3 0.0010
164 PORTAL HYPERTENSION 3 0.0010
165 COMPULSIVE SHOPPING 2 0.0010
166 VARICOSE VEIN 5 0.0010
167 FEEDING DISORDER NEONATAL 1 0.0010
168 FOETAL DISTRESS SYNDROME 2 0.0009
169 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
170 PHYSICAL DISABILITY 4 0.0009
171 ESSENTIAL TREMOR 1 0.0009
172 CLEFT LIP AND PALATE 1 0.0009
173 CRYPTORCHISM 1 0.0009
174 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
175 CORTISOL DECREASED 1 0.0009
176 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
177 LICHENOID KERATOSIS 2 0.0009
178 CARBON DIOXIDE DECREASED 1 0.0009
179 HAEMANGIOMA 2 0.0009
180 METABOLIC DISORDER 5 0.0009
181 HYPERTRIGLYCERIDAEMIA 5 0.0009
182 PRURITUS GENITAL 2 0.0008
183 NEONATAL RESPIRATORY DISTRESS SYNDROME 3 0.0008
184 SKIN ABRASION 4 0.0008
185 EYELID SKIN DRYNESS 1 0.0008
186 RASH PUSTULAR 6 0.0008
187 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
188 PYELONEPHRITIS 7 0.0008
189 ALLERGY TO CHEMICALS 1 0.0008
190 EYELID IRRITATION 2 0.0008
191 VASODILATATION 2 0.0008
192 GLAUCOMA 15 0.0008
193 CAESAREAN SECTION 9 0.0008
194 ANAEMIA POSTOPERATIVE 1 0.0008
195 PROSTATOMEGALY 3 0.0008
196 FURUNCLE 6 0.0008
197 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
198 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
199 CALCULUS BLADDER 1 0.0007
200 CLUSTER HEADACHE 1 0.0007
201 CORNEAL ABRASION 1 0.0007
202 RHINALGIA 2 0.0007
203 HYPERKERATOSIS 4 0.0007
204 DISCHARGE 1 0.0007
205 DEATH NEONATAL 1 0.0007
206 CULTURE URINE POSITIVE 1 0.0007
207 DIABETIC FOOT INFECTION 1 0.0007
208 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
209 ONYCHOMYCOSIS 3 0.0007
210 RHINITIS ALLERGIC 3 0.0007
211 WEIGHT FLUCTUATION 7 0.0007
212 PROTHROMBIN TIME PROLONGED 4 0.0007
213 PAROSMIA 5 0.0007
214 PROSTATITIS 2 0.0007
215 NEPHROGENIC ANAEMIA 3 0.0006
216 COAGULATION TIME PROLONGED 1 0.0006
217 MULTIPLE INJURIES 4 0.0006
218 EOSINOPHILIA 11 0.0006
219 STILLBIRTH 3 0.0006
220 RHINITIS 5 0.0006
221 BRADYARRHYTHMIA 1 0.0006
222 HYPERVOLAEMIA 3 0.0006
223 COLONIC POLYP 1 0.0006
224 OTITIS MEDIA 2 0.0006
225 ARTHROPOD STING 1 0.0006
226 THERAPEUTIC AGENT TOXICITY 2 0.0006
227 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
228 HYPERLIPIDAEMIA 7 0.0006
229 BLOOD SODIUM DECREASED 11 0.0006
230 NEPHROTIC SYNDROME 4 0.0006
231 HEPATIC FIBROSIS 2 0.0006
232 ONYCHOCLASIS 4 0.0006
233 TRISMUS 3 0.0006
234 NAIL DISORDER 5 0.0006
235 NECROTISING FASCIITIS 2 0.0006
236 FIBRIN D DIMER INCREASED 2 0.0006
237 AORTIC VALVE STENOSIS 1 0.0006
238 SKIN WEEPING 2 0.0006
239 APPLICATION SITE DISCOMFORT 1 0.0006
240 HEPATIC CYTOLYSIS 7 0.0005
241 UTERINE LEIOMYOMA 4 0.0005
242 VENTRICULAR ARRHYTHMIA 2 0.0005
243 HYPOMANIA 2 0.0005
244 INTRACRANIAL PRESSURE INCREASED 3 0.0005
245 CHRONIC SINUSITIS 2 0.0005
246 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
247 AUTOIMMUNE THYROIDITIS 2 0.0005
248 PARANASAL SINUS DISCOMFORT 2 0.0005
249 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
250 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
251 COMMUNICATION DISORDER 2 0.0005
252 FAECES HARD 2 0.0005
253 APLASIA 1 0.0005
254 WOUND SECRETION 2 0.0005
255 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
256 SKIN ODOUR ABNORMAL 2 0.0005
257 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
258 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
259 OEDEMA 27 0.0005
260 GANGRENE 3 0.0005
261 SENSORY LOSS 4 0.0005
262 INGUINAL HERNIA 3 0.0005
263 SPINAL STENOSIS 2 0.0005
264 ANAL PRURITUS 1 0.0005
265 PRE-EXISTING CONDITION IMPROVED 3 0.0005
266 FUNGAL INFECTION 16 0.0005
267 DEVICE CONNECTION ISSUE 1 0.0005
268 ANAEMIA MACROCYTIC 1 0.0005
269 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
270 ABNORMAL SENSATION IN EYE 2 0.0005
271 HYPOAESTHESIA ORAL 7 0.0005
272 SKIN ULCER 12 0.0005
273 ECONOMIC PROBLEM 7 0.0005
274 CERVICAL DYSPLASIA 1 0.0005
275 ANHEDONIA 12 0.0005
276 ASPIRATION 5 0.0005
277 ACCIDENT AT WORK 1 0.0005
278 BACTERIAL TEST POSITIVE 1 0.0004
279 MENINGIOMA 7 0.0004
280 FACIAL PAIN 4 0.0004
281 POST-TRAUMATIC STRESS DISORDER 3 0.0004
282 IMPLANT SITE PAIN 2 0.0004
283 ABNORMAL LOSS OF WEIGHT 3 0.0004
284 END STAGE RENAL DISEASE 8 0.0004
285 ABDOMINAL HERNIA 2 0.0004
286 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
287 LYMPHOEDEMA 3 0.0004
288 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
289 DYSMORPHISM 1 0.0004
290 HAND FRACTURE 3 0.0004
291 THERMAL BURN 3 0.0004
292 CHRONIC KIDNEY DISEASE 32 0.0004
293 PRE-ECLAMPSIA 2 0.0004
294 POST PROCEDURAL COMPLICATION 8 0.0004
295 DERMATITIS BULLOUS 3 0.0004
296 BRONCHITIS CHRONIC 1 0.0004
297 LIGAMENT SPRAIN 4 0.0004
298 DIABETIC NEUROPATHY 2 0.0004
299 APPLICATION SITE SWELLING 2 0.0004
300 GASTROINTESTINAL TUBE INSERTION 1 0.0004
301 TOXIC SKIN ERUPTION 4 0.0004
302 CHOLELITHIASIS 13 0.0004
303 OSTEOPENIA 6 0.0004
304 EXCORIATION 1 0.0004
305 DIABETIC COMPLICATION 1 0.0004
306 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
307 FOOD ALLERGY 3 0.0004
308 PERIPHERAL VASCULAR DISORDER 2 0.0004
309 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
310 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
311 FAILURE TO THRIVE 2 0.0004
312 TRICUSPID VALVE INCOMPETENCE 3 0.0004
313 ANORECTAL DISCOMFORT 2 0.0004
314 ANAL ABSCESS 2 0.0004
315 SKIN LACERATION 4 0.0004
316 HYDROCEPHALUS 2 0.0004
317 BLOOD PHOSPHORUS INCREASED 1 0.0004
318 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
319 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
320 EMBOLISM 3 0.0004
321 HEART RATE ABNORMAL 2 0.0004
322 ATRIAL SEPTAL DEFECT 3 0.0004
323 SKIN PLAQUE 3 0.0004
324 FACIAL PARALYSIS 3 0.0004
325 DERMATITIS CONTACT 4 0.0004
326 BRONCHOSPASM 5 0.0004
327 HYPERTONIA 2 0.0003
328 MOUTH SWELLING 2 0.0003
329 BLOOD URIC ACID INCREASED 2 0.0003
330 ANOSMIA 5 0.0003
331 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
332 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
333 CREPITATIONS 1 0.0003
334 GASTROINTESTINAL INFECTION 3 0.0003
335 BLOOD CULTURE POSITIVE 1 0.0003
336 WRIST FRACTURE 4 0.0003
337 ANAL INCONTINENCE 3 0.0003
338 HEAVY MENSTRUAL BLEEDING 3 0.0003
339 HEPATITIS CHOLESTATIC 2 0.0003
340 LACRIMATION INCREASED 10 0.0003
341 OSTEOARTHRITIS 14 0.0003
342 EMBOLISM VENOUS 1 0.0003
343 FOETAL GROWTH RESTRICTION 2 0.0003
344 INCREASED TENDENCY TO BRUISE 3 0.0003
345 PROCEDURAL PAIN 9 0.0003
346 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
347 DIASTOLIC DYSFUNCTION 1 0.0003
348 BRAIN DEATH 1 0.0003
349 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
350 DEMENTIA 9 0.0003
351 BLOOD CREATININE DECREASED 1 0.0003
352 ARTERIOSCLEROSIS 3 0.0003
353 SQUAMOUS CELL CARCINOMA 3 0.0003
354 PHOTOPSIA 2 0.0003
355 BLADDER PAIN 1 0.0003
356 BILE DUCT STONE 1 0.0003
357 SLEEP APNOEA SYNDROME 6 0.0003
358 EXPOSURE TO TOXIC AGENT 1 0.0003
359 SINUS BRADYCARDIA 3 0.0003
360 BLOOD POTASSIUM INCREASED 5 0.0003
361 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
362 BRADYPHRENIA 2 0.0003
363 ARTHRITIS 24 0.0003
364 DEAFNESS NEUROSENSORY 1 0.0003
365 STAPHYLOCOCCAL INFECTION 10 0.0003
366 APPETITE DISORDER 2 0.0003
367 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
368 TYPE 2 DIABETES MELLITUS 10 0.0003
369 APPLICATION SITE DRYNESS 1 0.0003
370 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
371 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
372 SKIN LESION 8 0.0003
373 MUSCULOSKELETAL DISCOMFORT 5 0.0003
374 HAIR GROWTH ABNORMAL 2 0.0003
375 CAROTID ARTERY STENOSIS 1 0.0003
376 MASS 4 0.0003
377 RENAL FAILURE 38 0.0003
378 BRONCHIOLITIS 1 0.0003
379 PAPULE 2 0.0003
380 HEAD DISCOMFORT 5 0.0003
381 DIVERTICULUM 2 0.0003
382 BREAST PAIN 3 0.0003
383 HEREDITARY ANGIOEDEMA 3 0.0003
384 TONGUE DISORDER 2 0.0003
385 TOOTHACHE 5 0.0003
386 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
387 HYPOPHOSPHATAEMIA 2 0.0003
388 CEREBRAL DISORDER 2 0.0003
389 VENTRICULAR FIBRILLATION 3 0.0003
390 BONE DENSITY ABNORMAL 1 0.0003
391 SKIN INFECTION 3 0.0003
392 BLOOD POTASSIUM DECREASED 8 0.0003
393 EYE INFECTION 3 0.0003
394 HYPERTHERMIA 2 0.0003
395 LIPASE INCREASED 2 0.0003
396 CHOLESTASIS 5 0.0003
397 CELLULITIS 13 0.0003
398 APHTHOUS ULCER 2 0.0003
399 BLOOD CHOLESTEROL INCREASED 12 0.0003
400 CHOKING 5 0.0003
401 SEXUAL DYSFUNCTION 3 0.0003
402 MULTIPLE ALLERGIES 2 0.0003
403 BACTERAEMIA 3 0.0003
404 NEUROPATHY PERIPHERAL 24 0.0003
405 HALLUCINATION, AUDITORY 4 0.0003
406 RASH ERYTHEMATOUS 12 0.0003
407 SCIATICA 4 0.0003
408 MUSCLE RIGIDITY 3 0.0003
409 AZOTAEMIA 1 0.0003
410 MYASTHENIA GRAVIS 2 0.0002
411 BURSITIS 3 0.0002
412 APPLICATION SITE DISCOLOURATION 1 0.0002
413 AGEUSIA 6 0.0002
414 DERMATITIS 5 0.0002
415 FLUID RETENTION 12 0.0002
416 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
417 AORTIC VALVE INCOMPETENCE 1 0.0002
418 ABSCESS LIMB 1 0.0002
419 SCAR 4 0.0002
420 CARDIAC MURMUR 2 0.0002
421 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
422 PLATELET COUNT INCREASED 3 0.0002
423 ECZEMA 12 0.0002
424 DIVERTICULUM INTESTINAL 1 0.0002
425 ABNORMAL BEHAVIOUR 9 0.0002
426 IMMUNOSUPPRESSION 2 0.0002
427 LUNG INFILTRATION 2 0.0002
428 GINGIVAL SWELLING 1 0.0002
429 PURPURA 2 0.0002
430 TOOTH DISORDER 5 0.0002
431 GLOSSODYNIA 5 0.0002
432 GOUT 4 0.0002
433 PAIN OF SKIN 6 0.0002
434 DEVELOPMENTAL DELAY 2 0.0002
435 CHROMATURIA 5 0.0002
436 TACHYPNOEA 3 0.0002
437 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
438 MOOD ALTERED 6 0.0002
439 HIDRADENITIS 2 0.0002
440 TINNITUS 10 0.0002
441 CHRONIC MYELOID LEUKAEMIA 1 0.0002
442 RHINORRHOEA 14 0.0002
443 ARTHRITIS INFECTIVE 1 0.0002
444 DEEP VEIN THROMBOSIS 14 0.0002
445 DRUG INTERACTION 34 0.0002
446 DIARRHOEA HAEMORRHAGIC 2 0.0002
447 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
448 EYE PAIN 12 0.0002
449 LYMPHOPENIA 3 0.0002
450 COLITIS MICROSCOPIC 1 0.0002
451 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
452 PRODUCT PACKAGING ISSUE 2 0.0002
453 FAECAL INCONTINENCE 1 0.0002
454 HYPERCHOLESTEROLAEMIA 2 0.0002
455 ATELECTASIS 2 0.0002
456 FINGER DEFORMITY 1 0.0002
457 EAR PAIN 4 0.0002
458 PRESYNCOPE 5 0.0002
459 VITAMIN D DEFICIENCY 2 0.0002
460 LUNG DISORDER 10 0.0002
461 RENAL TUBULAR NECROSIS 2 0.0002
462 BREATH SOUNDS ABNORMAL 1 0.0002
463 URINARY INCONTINENCE 6 0.0002
464 FOOT OPERATION 1 0.0002
465 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
466 ABDOMINAL TENDERNESS 1 0.0002
467 ERYSIPELAS 1 0.0002
468 APHASIA 6 0.0002
469 DRY MOUTH 16 0.0002
470 TOOTH ABSCESS 2 0.0002
471 HEPATITIS 5 0.0002
472 NEUTROPHIL COUNT INCREASED 2 0.0002
473 FEMORAL NECK FRACTURE 1 0.0002
474 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
475 ERECTILE DYSFUNCTION 5 0.0002
476 INFLAMMATION 10 0.0002
477 C-REACTIVE PROTEIN INCREASED 7 0.0002
478 MUSCULOSKELETAL PAIN 10 0.0002
479 CYANOSIS 3 0.0002
480 INJECTION SITE DISCOMFORT 2 0.0002
481 MOUTH ULCERATION 4 0.0002
482 SCRATCH 2 0.0002
483 JOINT DISLOCATION 2 0.0002
484 BRONCHITIS 14 0.0002
485 FULL BLOOD COUNT ABNORMAL 2 0.0002
486 ABSCESS 3 0.0002
487 JOINT INJURY 4 0.0002
488 ANAL FISSURE 1 0.0002
489 BRUXISM 1 0.0002
490 DECREASED ACTIVITY 2 0.0002
491 CHEILITIS 1 0.0002
492 OESOPHAGITIS 2 0.0002
493 FAECALOMA 1 0.0002
494 GASTROINTESTINAL PAIN 2 0.0002
495 APPLICATION SITE PAIN 4 0.0002
496 NECK PAIN 10 0.0002
497 MALNUTRITION 2 0.0002
498 ANGIOPATHY 1 0.0002
499 SNEEZING 4 0.0002
500 OCULAR DISCOMFORT 2 0.0002
501 MITRAL VALVE INCOMPETENCE 2 0.0002
502 SCAB 2 0.0002
503 CARDIAC VALVE DISEASE 1 0.0002
504 SKIN DISCOLOURATION 8 0.0002
505 RENAL DISORDER 8 0.0002
506 BURNING SENSATION 12 0.0002
507 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
508 SURGERY 10 0.0002
509 URINARY TRACT INFECTION 29 0.0002
510 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
511 BLOOD IRON DECREASED 2 0.0002
512 RENAL INJURY 5 0.0002
513 CARDIAC PACEMAKER INSERTION 1 0.0002
514 IRRITABILITY 10 0.0002
515 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
516 GASTROENTERITIS VIRAL 3 0.0002
517 CRYING 6 0.0002
518 RESTLESS LEGS SYNDROME 3 0.0002
519 ADRENAL INSUFFICIENCY 2 0.0002
520 DERMATITIS ACNEIFORM 1 0.0002
521 VERTIGO 10 0.0002
522 TENDON RUPTURE 2 0.0002
523 HYPERCALCAEMIA 2 0.0002
524 ABNORMAL WEIGHT GAIN 2 0.0002
525 CONJUNCTIVITIS 3 0.0002
526 PHARYNGITIS 2 0.0002
527 HAIR COLOUR CHANGES 2 0.0002
528 SWOLLEN TONGUE 5 0.0002
529 INJECTION SITE DISCOLOURATION 2 0.0002
530 DYSPNOEA EXERTIONAL 6 0.0002
531 DERMATITIS ALLERGIC 2 0.0002
532 BLEPHAROSPASM 1 0.0002
533 BLOOD URINE PRESENT 3 0.0002
534 GASTRIC ULCER 3 0.0002
535 INCREASED APPETITE 3 0.0002
536 FOREIGN BODY SENSATION IN EYES 1 0.0002
537 INTRAOCULAR PRESSURE INCREASED 2 0.0002
538 SLEEP DISORDER 11 0.0002
539 ROTATOR CUFF SYNDROME 2 0.0002
540 ERUCTATION 3 0.0002
541 CARDIAC FLUTTER 1 0.0002
542 LACTIC ACIDOSIS 5 0.0002
543 HAEMATOMA 4 0.0002
544 INJECTION SITE INDURATION 2 0.0002
545 NODULE 2 0.0002
546 BLOOD CREATININE INCREASED 10 0.0002
547 SKIN IRRITATION 7 0.0002
548 IMPAIRED HEALING 5 0.0002
549 ORAL CANDIDIASIS 2 0.0002
550 TOOTH INFECTION 2 0.0002
551 PULMONARY CONGESTION 2 0.0002
552 UPPER LIMB FRACTURE 3 0.0002
553 SKIN DISORDER 5 0.0001
554 CHOLECYSTITIS CHRONIC 1 0.0001
555 MALIGNANT MELANOMA 2 0.0001
556 TASTE DISORDER 3 0.0001
557 BONE MARROW FAILURE 3 0.0001
558 DYSPHAGIA 14 0.0001
559 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
560 ANAEMIA 28 0.0001
561 PRODUCTIVE COUGH 7 0.0001
562 GAIT DISTURBANCE 28 0.0001
563 BLOOD TESTOSTERONE DECREASED 1 0.0001
564 HAEMATURIA 5 0.0001
565 CROHN'S DISEASE 1 0.0001
566 CORONARY ARTERY OCCLUSION 2 0.0001
567 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
568 PERIPHERAL COLDNESS 2 0.0001
569 PULMONARY HYPERTENSION 3 0.0001
570 ACUTE KIDNEY INJURY 22 0.0001
571 FORMICATION 1 0.0001
572 COORDINATION ABNORMAL 2 0.0001
573 EXTRASYSTOLES 1 0.0001
574 RASH MACULAR 5 0.0001
575 PERIPHERAL SWELLING 22 0.0001
576 KNEE ARTHROPLASTY 3 0.0001
577 BLOOD TEST ABNORMAL 2 0.0001
578 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
579 APPLICATION SITE REACTION 1 0.0001
580 HYPONATRAEMIA 8 0.0001
581 PAIN IN JAW 4 0.0001
582 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
583 FEAR OF INJECTION 1 0.0001
584 POOR QUALITY SLEEP 3 0.0001
585 SKIN CANCER 3 0.0001
586 IMPAIRED QUALITY OF LIFE 2 0.0001
587 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
588 BALANCE DISORDER 12 0.0001
589 BACK PAIN 32 0.0001
590 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
591 ACCIDENTAL OVERDOSE 5 0.0001
592 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
593 SKIN HAEMORRHAGE 2 0.0001
594 IMMUNODEFICIENCY 2 0.0001
595 PREMATURE BABY 4 0.0001
596 DERMATITIS ATOPIC 7 0.0001
597 INTESTINAL OBSTRUCTION 5 0.0001
598 APPLICATION SITE PRURITUS 3 0.0001
599 CORONARY ARTERY DISEASE 4 0.0001
600 DEVICE RELATED INFECTION 2 0.0001
601 DISTURBANCE IN ATTENTION 7 0.0001
602 RASH PRURITIC 7 0.0001
603 APNOEA 1 0.0001
604 THERAPY PARTIAL RESPONDER 2 0.0001
605 BASAL CELL CARCINOMA 2 0.0001
606 GASTROINTESTINAL INFLAMMATION 1 0.0001
607 DEPRESSION 29 0.0001
608 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
609 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
610 SINUSITIS 13 0.0001
611 ANXIETY 36 0.0001
612 COVID-19 22 0.0001
613 WEIGHT INCREASED 28 0.0001
614 CARDIAC FAILURE 10 0.0001
615 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
616 NIGHT SWEATS 4 0.0001
617 LOCALISED INFECTION 3 0.0001
618 NEURALGIA 3 0.0001
619 DECUBITUS ULCER 1 0.0001
620 PRODUCT DOSE OMISSION 8 0.0001
621 AGITATION 9 0.0001
622 EYE DISORDER 4 0.0001
623 ERYTHEMA 25 0.0001
624 ESCHERICHIA INFECTION 1 0.0001
625 PHOTOSENSITIVITY REACTION 2 0.0001
626 EXPIRED PRODUCT ADMINISTERED 4 0.0001
627 DRY EYE 6 0.0001
628 VIRAL INFECTION 4 0.0001
629 EOSINOPHIL COUNT INCREASED 1 0.0001
630 INJECTION SITE PRURITUS 8 0.0001
631 SKIN EXFOLIATION 10 0.0001
632 CANDIDA INFECTION 2 0.0001
633 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
634 MEMORY IMPAIRMENT 16 0.0001
635 OEDEMA PERIPHERAL 14 0.0001
636 RASH 50 0.0001
637 SPEECH DISORDER 6 0.0001
638 APPLICATION SITE ERYTHEMA 3 0.0001
639 NASOPHARYNGITIS 21 0.0001
640 LYMPHADENOPATHY 4 0.0001
641 VISUAL IMPAIRMENT 14 0.0001
642 EAR INFECTION 3 0.0001
643 DRY SKIN 15 0.0001
644 ISCHAEMIC STROKE 2 0.0001
645 CARDIAC FAILURE CONGESTIVE 9 0.0001
646 DYSPEPSIA 11 0.0001
647 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
648 LIMB INJURY 3 0.0001
649 TREATMENT NONCOMPLIANCE 6 0.0001
650 EXOSTOSIS 1 0.0001
651 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
652 NEPHROLITHIASIS 5 0.0001
653 BRAIN NEOPLASM 1 0.0001
654 DIVERTICULITIS 3 0.0001
655 MENTAL STATUS CHANGES 3 0.0001
656 EYE SWELLING 4 0.0001
657 THINKING ABNORMAL 2 0.0001
658 BACTERIAL INFECTION 2 0.0001
659 HYPOAESTHESIA 16 0.0001
660 ABORTION INDUCED 1 0.0001
661 HYPOCALCAEMIA 2 0.0001
662 OCULAR HYPERAEMIA 5 0.0001
663 PULMONARY EMBOLISM 10 0.0001
664 HAEMORRHAGE 11 0.0001
665 ACUTE RESPIRATORY FAILURE 2 0.0001
666 AFFECT LABILITY 1 0.0001
667 PANCREATIC CARCINOMA 3 0.0001
668 CONTUSION 10 0.0001
669 HYPERTENSION 22 0.0001
670 ASTHENIA 39 0.0001
671 PRESCRIBED OVERDOSE 2 0.0001
672 PLATELET COUNT DECREASED 11 0.0001
673 DIZZINESS POSTURAL 1 0.0001
674 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
675 HAEMORRHOIDS 2 0.0001
676 ORAL HERPES 2 0.0001
677 FALL 34 0.0001
678 NASAL CONGESTION 6 0.0001
679 ASCITES 3 0.0001
680 VISION BLURRED 14 0.0001
681 BODY TEMPERATURE DECREASED 1 0.0001
682 PRURITUS 39 0.0001
683 WHEEZING 6 0.0001
684 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
685 SINUS DISORDER 2 0.0001
686 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
687 BLOOD PRESSURE ABNORMAL 2 0.0001
688 PREGNANCY 2 0.0001
689 FULL BLOOD COUNT DECREASED 2 0.0001
690 EMOTIONAL DISTRESS 12 0.0001
691 SEPSIS 11 0.0001
692 PAIN IN EXTREMITY 29 0.0001
693 DRY THROAT 1 0.0001
694 DEHYDRATION 13 0.0001
695 HAEMOGLOBIN DECREASED 10 0.0001
696 OSTEOPOROSIS 4 0.0001
697 RIB FRACTURE 2 0.0001
698 LIMB DISCOMFORT 3 0.0001
699 MUSCULAR WEAKNESS 11 0.0001
700 TOOTH LOSS 2 0.0001
701 CARDIO-RESPIRATORY ARREST 4 0.0001
702 ROAD TRAFFIC ACCIDENT 4 0.0001
703 NEUTROPENIA 13 0.0001
704 HEAD INJURY 3 0.0001
705 HALLUCINATION, VISUAL 2 0.0001
706 EATING DISORDER 2 0.0001
707 BODY HEIGHT DECREASED 1 0.0001
708 COUGH 26 0.0001
709 PRURITUS GENERALISED 2 0.0001
710 PYREXIA 32 0.0001
711 ATRIAL FIBRILLATION 9 0.0001
712 ACNE 7 0.0001
713 BIPOLAR DISORDER 1 0.0001
714 PRODUCT DISPENSING ERROR 2 0.0001
715 CHEST PAIN 17 0.0001
716 MUSCULOSKELETAL STIFFNESS 8 0.0001
717 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
718 DENTAL CARIES 1 0.0001
719 FOOT DEFORMITY 1 0.0001
720 RASH MACULO-PAPULAR 2 0.0001
721 ORAL PAIN 2 0.0001
722 EYE PRURITUS 3 0.0001
723 RASH PAPULAR 2 0.0001
724 PARAESTHESIA 14 0.0001
725 CHEST DISCOMFORT 9 0.0001
726 INJECTION SITE REACTION 6 0.0001
727 HERPES ZOSTER 5 0.0001
728 GASTRIC HAEMORRHAGE 1 0.0001
729 HYPOKALAEMIA 4 0.0001
730 CONFUSIONAL STATE 14 0.0001
731 ALOPECIA 17 0.0001
732 PERICARDIAL EFFUSION 2 0.0001
733 OROPHARYNGEAL PAIN 8 0.0001
734 EYELID OEDEMA 1 0.0001
735 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
736 HYPERKALAEMIA 3 0.0001
737 CONDITION AGGRAVATED 26 0.0001
738 DYSPHONIA 5 0.0001
739 HEART RATE DECREASED 3 0.0001
740 INJURY 6 0.0001
741 BONE PAIN 5 0.0001
742 HYPOXIA 3 0.0001
743 DYSPNOEA 48 0.0001
744 CEREBRAL HAEMORRHAGE 3 0.0001
745 ACCIDENT 1 0.0001
746 DIABETIC KETOACIDOSIS 2 0.0001
747 SUICIDE ATTEMPT 5 0.0001
748 WEIGHT DECREASED 23 0.0001
749 FIBROMYALGIA 2 0.0001
750 DIZZINESS 41 0.0001
751 PLEURAL EFFUSION 5 0.0001
752 CEREBRAL INFARCTION 2 0.0001
753 MUSCLE SPASMS 15 0.0001
754 ENCEPHALOPATHY 2 0.0001
755 CARDIOMEGALY 1 0.0001
756 INJECTION SITE MASS 3 0.0001
757 FATIGUE 63 0.0001
758 GENERALISED OEDEMA 1 0.0001
759 CYST 1 0.0001
760 EXPOSURE DURING PREGNANCY 5 0.0001
761 APPLICATION SITE IRRITATION 1 0.0001
762 EPISTAXIS 6 0.0001
763 PNEUMONIA ASPIRATION 2 0.0001
764 HYPOTENSION 16 0.0001
765 HOT FLUSH 6 0.0001
766 ARTHRALGIA 33 0.0001
767 DIABETES MELLITUS 6 0.0001
768 TREMOR 13 0.0001
769 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
770 UNRESPONSIVE TO STIMULI 2 0.0001
771 RASH GENERALISED 2 0.0001
772 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
773 PAIN 47 0.0001
774 BEDRIDDEN 1 0.0001
775 GASTRITIS 2 0.0001
776 ADVERSE REACTION 1 0.0001
777 FEBRILE NEUTROPENIA 5 0.0001
778 EYE HAEMORRHAGE 1 0.0001
779 FEAR 2 0.0001
780 PALLOR 2 0.0001
781 DRUG TOXICITY 1 0.0001
782 CONSTIPATION 16 0.0001
783 MIGRAINE 7 0.0001
784 DECREASED APPETITE 17 0.0001
785 ACUTE HEPATIC FAILURE 1 0.0001
786 ABDOMINAL PAIN UPPER 15 0.0001
787 APPLICATION SITE RASH 1 0.0001
788 RESPIRATORY DISTRESS 2 0.0001
789 ARTHROPATHY 4 0.0001
790 POLLAKIURIA 3 0.0001
791 APHONIA 1 0.0001
792 BLISTER 4 0.0001
793 OXYGEN SATURATION DECREASED 4 0.0001
794 BLINDNESS UNILATERAL 1 0.0001
795 RENAL FAILURE ACUTE 3 0.0001
796 MALAISE 31 0.0001
797 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
798 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
799 INTENTIONAL DOSE OMISSION 2 0.0001
800 RED BLOOD CELL COUNT DECREASED 2 0.0001
801 HYPERSOMNIA 2 0.0001
802 DIARRHOEA 45 0.0001
803 LETHARGY 4 0.0001
804 SEIZURE 8 0.0001
805 DEVICE DISLOCATION 3 0.0001
806 SEPTIC SHOCK 3 0.0001
807 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
808 LIVER FUNCTION TEST ABNORMAL 2 0.0001
809 FLUID OVERLOAD 1 0.0001
810 NEEDLE ISSUE 2 0.0001
811 APATHY 1 0.0001
812 DYSSTASIA 2 0.0001
813 ACUTE MYOCARDIAL INFARCTION 2 0.0001
814 LABORATORY TEST ABNORMAL 2 0.0001
815 CARDIOMYOPATHY 1 0.0001
816 INSOMNIA 18 0.0001
817 RESPIRATORY DISORDER 2 0.0001
818 BONE LOSS 1 0.0001
819 HALLUCINATION 5 0.0001
820 UNEVALUABLE EVENT 5 0.0001
821 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
822 STOMATITIS 4 0.0001
823 VOMITING 31 0.0001
824 ILL-DEFINED DISORDER 4 0.0001
825 URTICARIA 11 0.0001
826 DISCOMFORT 4 0.0001
827 FEELING HOT 4 0.0001
828 INJECTION SITE RASH 2 0.0001
829 ANKLE FRACTURE 1 0.0001
830 FEMUR FRACTURE 2 0.0001
831 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
832 SOMNOLENCE 13 0.0001
833 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
834 DELUSION 1 0.0001
835 NERVOUS SYSTEM DISORDER 2 0.0001
836 BRAIN FOG 1 0.0001
837 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
838 CYSTITIS 2 0.0001
839 INFLUENZA 7 0.0001
840 INJECTION SITE BRUISING 5 0.0001
841 HYPOTHYROIDISM 2 0.0001
842 HEADACHE 39 0.0001
843 HYPERHIDROSIS 8 0.0001
844 BACK DISORDER 1 0.0001
845 PSORIASIS 8 0.0001
846 OSTEONECROSIS 2 0.0001
847 NAUSEA 48 0.0001
848 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
849 COAGULOPATHY 1 0.0001
850 SYNCOPE 6 0.0001
851 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
852 BLOOD UREA INCREASED 1 0.0001
853 RENAL IMPAIRMENT 5 0.0001
854 DISEASE PROGRESSION 7 0.0001
855 BLOOD GLUCOSE INCREASED 11 0.0001
856 GASTRIC DISORDER 2 0.0001
857 ILLNESS 6 0.0001
858 NIGHTMARE 2 0.0001
859 DEVICE DEFECTIVE 1 0.0001
860 ABDOMINAL DISTENSION 6 0.0001
861 PRODUCT STORAGE ERROR 5 0.0001
862 PANCREATITIS 3 0.0001
863 DEPRESSED MOOD 3 0.0001
864 COLD SWEAT 1 0.0001
865 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
866 DRUG ERUPTION 1 0.0001
867 GALLBLADDER DISORDER 1 0.0001
868 DEVICE ISSUE 5 0.0001
869 DRUG EFFECT DECREASED 3 0.0001
870 MOBILITY DECREASED 4 0.0001
871 PNEUMONIA 18 0.0001
872 HYPERGLYCAEMIA 2 0.0001
873 BONE DISORDER 1 0.0001
874 RESPIRATORY FAILURE 4 0.0001
875 SUICIDAL IDEATION 5 0.0001
876 HAEMATOCHEZIA 3 0.0001
877 DYSGEUSIA 4 0.0001
878 PANCYTOPENIA 3 0.0001
879 SWELLING 5 0.0001
880 DYSARTHRIA 2 0.0001
881 MYALGIA 9 0.0001
882 FRACTURE 1 0.0001
883 COLITIS 2 0.0001
884 FOOT FRACTURE 1 0.0001
885 CONVULSION 3 0.0001
886 DYSTONIA 1 0.0001
887 PRODUCT DOSE OMISSION ISSUE 15 0.0001
888 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
889 CATARACT 3 0.0001
890 ABORTION SPONTANEOUS 2 0.0000
891 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
892 BLINDNESS 2 0.0000
893 WITHDRAWAL SYNDROME 2 0.0000
894 ABDOMINAL PAIN 11 0.0000
895 INTENTIONAL OVERDOSE 3 0.0000
896 RECTAL HAEMORRHAGE 2 0.0000
897 HYPOACUSIS 2 0.0000
898 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
899 SWELLING FACE 3 0.0000
900 MYOCARDIAL INFARCTION 8 0.0000
901 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
902 INTENTIONAL PRODUCT MISUSE 4 0.0000
903 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
904 ANGIOEDEMA 2 0.0000
905 NEOPLASM MALIGNANT 3 0.0000
906 DRUG INEFFECTIVE 59 0.0000
907 THROMBOCYTOPENIA 5 0.0000
908 GASTROINTESTINAL DISORDER 4 0.0000
909 THERAPY NON-RESPONDER 2 0.0000
910 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
911 RHEUMATOID ARTHRITIS 5 0.0000
912 HYPERSENSITIVITY 8 0.0000
913 COGNITIVE DISORDER 2 0.0000
914 ARRHYTHMIA 2 0.0000
915 SKIN BURNING SENSATION 3 0.0000
916 BLOOD PRESSURE FLUCTUATION 1 0.0000
917 HYPOGLYCAEMIA 2 0.0000
918 EXTRAPYRAMIDAL DISORDER 1 0.0000
919 GASTRIC CANCER 1 0.0000
920 INCORRECT DOSE ADMINISTERED 9 0.0000
921 ANAPHYLACTIC SHOCK 1 0.0000
922 NERVOUSNESS 2 0.0000
923 DEAFNESS 1 0.0000
924 BREAST CANCER FEMALE 1 0.0000
925 FREQUENT BOWEL MOVEMENTS 1 0.0000
926 CARDIAC ARREST 3 0.0000
927 DRUG DOSE OMISSION 6 0.0000
928 FEELING COLD 1 0.0000
929 ABDOMINAL DISCOMFORT 6 0.0000
930 ASTHMA 4 0.0000
931 INFECTION 5 0.0000
932 OFF LABEL USE 30 0.0000
933 CHILLS 4 0.0000
934 TACHYCARDIA 3 0.0000
935 ADVERSE DRUG REACTION 3 0.0000
936 JOINT SWELLING 4 0.0000
937 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
938 THERAPEUTIC RESPONSE DECREASED 2 0.0000
939 EPILEPSY 1 0.0000
940 BLOOD PRESSURE INCREASED 5 0.0000
941 INJECTION SITE ERYTHEMA 4 0.0000
942 BREAST CANCER 3 0.0000
943 PRODUCT USE ISSUE 6 0.0000
944 BONE DENSITY DECREASED 1 0.0000
945 DRUG-INDUCED LIVER INJURY 1 0.0000
946 LOSS OF CONSCIOUSNESS 4 0.0000
947 AMNESIA 2 0.0000
948 INFUSION RELATED REACTION 2 0.0000
949 BLOOD PRESSURE DECREASED 2 0.0000
950 GAIT INABILITY 1 0.0000
951 ANGER 1 0.0000
952 CEREBROVASCULAR ACCIDENT 5 0.0000
953 FLUSHING 3 0.0000
954 PRODUCT QUALITY ISSUE 4 0.0000
955 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
956 DELIRIUM 1 0.0000
957 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
958 THERAPY INTERRUPTED 2 0.0000
959 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
960 DRUG EFFECT INCOMPLETE 1 0.0000
961 DYSURIA 1 0.0000
962 INJECTION SITE SWELLING 2 0.0000
963 INJECTION SITE PAIN 8 0.0000
964 PALPITATIONS 3 0.0000
965 DISORIENTATION 1 0.0000
966 FEELING ABNORMAL 6 0.0000
967 DRUG DEPENDENCE 4 0.0000
968 EXTRA DOSE ADMINISTERED 1 0.0000
969 DEVICE BREAKAGE 1 0.0000
970 DYSKINESIA 1 0.0000
971 DEATH 20 0.0000
972 DRUG WITHDRAWAL SYNDROME 2 0.0000
973 COLITIS ULCERATIVE 1 0.0000
974 DISEASE RECURRENCE 1 0.0000
975 COMA 1 0.0000
976 BLOOD GLUCOSE DECREASED 1 0.0000
977 DRUG INTOLERANCE 2 0.0000
978 AGGRESSION 1 0.0000
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
980 BRADYCARDIA 1 0.0000
981 OVERDOSE 4 0.0000
982 ANAPHYLACTIC REACTION 1 0.0000
983 FLATULENCE 1 0.0000
984 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
985 NO ADVERSE EVENT 3 0.0000
986 HOSPITALISATION 2 0.0000
987 DRUG ABUSE 1 0.0000
988 TOXICITY TO VARIOUS AGENTS 2 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000